معرفی
Jukka Rantanen serves as Professor and Head of the Department of Pharmacy within the Faculty of Health and Medical Sciences at the University of Copenhagen. Since joining the faculty in 2006 after postdoctoral training at Purdue University, he has established leadership roles including Chairman of the EUFEPS QbD and PAT Sciences Network Steering Committee and membership in the European Pharmacopoeia Commission's Process Analytical Technology Working Party.
Education:
- Docent in Physical Pharmacy, University of Helsinki (2001)
- PhD in Pharmacy, University of Helsinki (2001)
Research Focus: Professor Rantanen pioneers Process Analytical Technology (PAT) and innovative pharmaceutical manufacturing, with expertise spanning solid-state chemistry, crystallization science, and data-driven drug production. His work bridges additive manufacturing (3D printing of combination drugs), blockchain security for medications, and advanced granulation processes, driving industry adoption of Quality by Design principles.
Research Trends: Recent publications (2023-2025) demonstrate intensified focus on computational approaches (CSD data mining for hydrate prediction), personalized medicine stability challenges, and manufacturing robustness. His team actively develops blockchain-based authentication systems while optimizing twin-screw granulation parameters for commercial-scale production.
Scientific Recognition:
- APV Research Award for Outstanding Achievements in Pharmaceutical Sciences (2016)
Academic Leadership: With supervision of 40+ PhD students and editorial roles at leading pharmaceutical journals, Rantanen shapes next-generation scientists. His research attracts significant industry funding through collaborations with 20+ international companies, particularly in solid-state chemistry consulting and litigation support. Former service on Denmark's Council for Independent Research (2013-2018) highlights policy influence.
Research Infrastructure: Leads a multidisciplinary team at Copenhagen investigating real-time process monitoring, crystallization control, and 3D-printed drug products. Current projects include EUFEPS network initiatives advancing PAT implementation across European pharmaceutical manufacturing facilities.
